References
- Ge MQ, Ho AW, Tang Y, et al. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms. J Immunol 2012;189:2099–2109
- Lee SJ, Dunmire S, McSorley SJ. MHC class-I-restricted CD8 T cells play a protective role during primary Salmonella infection. Immunol Lett 2012;148:138–143
- Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86–89
- Gillis S, Smith KA. Long term culture of tumour-specific cytotoxic T cells. Nature 1977;268:154–156
- Vogler BK, Pittler MH, Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol 1999;55:567–575
- Christensen LP. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 2009;55:1–99
- Jia WW, Bu X, Philips D, et al. Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy. Can J Physiol Pharmacol 2004;82:431–437
- Li B, Zhao J, Wang CZ, et al. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett 2011;301:185–192
- Jiang YS, Jin ZX, Umehara H, Ota T. Cholesterol-dependent induction of dendrite formation by ginsenoside Rh2 in cultured melanoma cells. Int J Mol Med 2010;26:787–793
- Adachi Y, Ohno N, Ohsawa M, et al. Physiochemical properties and antitumor activities of chemically modified derivatives of antitumor glucan “grifolan LE” from Grifola frondosa. Chem Pharm Bull (Tokyo) 1989;37:1838–1843
- Fu BD, Bi WY, He CL, et al. Sulfated derivatives of 20 (S)-ginsenoside Rh2 and their inhibitory effects on LPS-induced inflammatory cytokines and mediators. Fitoterapia 2013;84:303–307
- Wu JH, Luo ZM, Zheng JU, Wang ZY. Discrimination of ginsengs of FTIR. J Instrum Anal 2003;3:75–77
- Yang XW, Hao MR, Masao H. Metabolite analysis for chemical constituents of traditional Chinese medicine. 1st ed. Beijing: China Medico-Pharmaceutical Science & Technology Publishing House; 2003:175–413
- Welte T, Leitenberg D, Dittel BN, et al. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science 1999;283:222–225
- Rincón M, Pedraza-Alva G. JNK and p38 MAP kinases in CD4+ and CD8+ T cells. Immunol Rev 2003;192:131–142
- Szabo SJ, Sullivan BM, Stemmann C, et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 2002;295:338–342
- Li Y, Huang W, Huang S, et al. Screening of anti-cancer agent using zebrafish: comparison with the MTT assay. Biochem Biophys Res Commun 2012;422:85–90
- Hans G, Biberfeld G. Measurement of lymphoproliferation at the single-cell level by flow cytometry. In: Kearse KP, ed. T cell protocols. Totowa (NJ): Humana Press; 2000:243--255
- Cao M, Zhang J, Zhao Y, et al. Advances in ginsenoside Rh2 and its derivatives. World Sci Technol Modern Tradit Chin Med 2012;14:2205–2211
- Li W, Yin JY, Cong ZY, et al. Anti-colon carcinoma cell activity of ginsenosides from the acid hydrolysate of Panax ginseng. Chem Nat Compd 2013;48:1017–1020
- Cho JY, Kim AR, Yoo ES, et al. Ginsenosides from Panax ginseng differentially regulate lymphocyte proliferation. Planta Med 2002;68:497–500
- Gu Y, Wang GJ, Sun JG, et al. Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs. Food Chem Toxicol 2009;47:2257–2268
- Yang Z, Gao S, Wang J, et al. Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms. Drug Metab Dispos 2011;39:1866–1872
- Gu Y, Wang GJ, Wu XL, et al. Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transporters. Xenobiotica 2010;40:602–612
- Fu BD, Bi WY, He CL, et al. Sulfated derivatives of 20(S)-ginsenoside Rh2 and their inhibitory effects on LPS-induced inflammatory cytokines and mediators. Fitoterapia 2013;84:303–307
- Yi PF, Bi WY, Shen HQ, et al. Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cells. Eur J Pharmacol 2013;712:60–66
- Zhu W, Fu BD, Wang L, et al. Effect of 20(S)-ginsenoside Rh2 sulfated derivatives on the macrophage competence. Chin J Vet Sci 2011;31:394–398
- Wang L, Fu BD, Guo ZT, et al. Regulating effect of sulfated total saponin of Panax ginseng on function of immune competent cell: an in vitro experiment. Chin J Vet Sci 2009;29:199–202
- Mo W, Zhang L, Yang G, et al. Nuclear beta-arrestin1 functions as a scaffold for the dephosphorylation of STAT1 and moderates the antiviral activity of IFN-γ. Mol Cell 2008;31:695–707
- Wesoly J, Szweykowska-Kulinska Z, Bluyssen HA. STAT activation and differential complex formation dictate selectivity of interferon responses. Acta Biochim Pol 2007;54:27–38
- Merritt C, Enslen H, Diehl N, et al. Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8(+) but not CD4(+) T cells. Mol Cell Biol 2000;20:936–946
- Stahelin RV, Digman MA, Medkova M, et al. Diacylglycerol-induced membrane targeting and activation of protein kinase Cepsilon: mechanistic differences between protein kinases Cdelta and Cepsilon. J Biol Chem 2005;280:19784–19793
- Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol 2009;27:591–619
- Chen C, Edelstein LC, Gelinas C. The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 2000;20:2687–2695